• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在芬兰老年人中,针对 2009 年甲型 H1N1 流感病毒的交叉反应性抗体的高频出现。

High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland.

机构信息

Viral Infections Unit, National Institute for Health and Welfare (THL), Helsinki, Finland.

出版信息

Euro Surveill. 2010 Feb 4;15(5):19478.

PMID:20144443
Abstract

Since May 2009, the pandemic influenza A(H1N1) virus has been spreading throughout the world. Epidemiological data indicate that the elderly are underrepresented among the ill individuals. Approximately 1,000 serum specimens collected in Finland in 2004 and 2005 from individuals born between 1909 and 2005, were analysed by haemagglutination-inhibition test for the presence of antibodies against the 2009 pandemic influenza A(H1N1) and recently circulating seasonal influenza A viruses. Ninety-six per cent of individuals born between 1909 and 1919 had antibodies against the 2009 pandemic influenza virus, while in age groups born between 1920 and 1944, the prevalence varied from 77% to 14%. Most individuals born after 1944 lacked antibodies to the pandemic virus. In sequence comparisons the haemagglutinin (HA) gene of the 2009 pandemic influenza A(H1N1) virus was closely related to that of the Spanish influenza and 1976 swine influenza viruses. Based on the three-dimensional structure of the HA molecule, the antigenic epitopes of the pandemic virus HA are more closely related to those of the Spanish influenza HA than to those of recent seasonal influenza A(H1N1) viruses. Among the elderly, cross-reactive antibodies against the 2009 pandemic influenza virus, which likely originate from infections caused by the Spanish influenza virus and its immediate descendants, may provide protective immunity against the present pandemic virus.

摘要

自 2009 年 5 月以来,甲型 H1N1 流感大流行病毒在全球范围内传播。流行病学数据表明,老年人在患病个体中代表性不足。2004 年和 2005 年,芬兰从 1909 年至 2005 年出生的个体中采集了约 1000 份血清标本,通过血凝抑制试验分析了这些标本中针对 2009 年甲型 H1N1 大流行流感病毒和最近流行的季节性 A 型流感病毒的抗体。在 1909 年至 1919 年出生的个体中,有 96%的个体具有针对 2009 年大流行流感病毒的抗体,而在 1920 年至 1944 年出生的年龄组中,流行率从 77%到 14%不等。大多数 1944 年后出生的个体缺乏针对大流行病毒的抗体。在序列比较中,2009 年甲型 H1N1 大流行流感病毒的血凝素(HA)基因与西班牙流感病毒和 1976 年猪流感病毒密切相关。基于 HA 分子的三维结构,大流行病毒 HA 的抗原表位与西班牙流感病毒的 HA 更为接近,而与最近的季节性 A(H1N1)病毒的 HA 则不太接近。在老年人中,针对 2009 年大流行流感病毒的交叉反应性抗体可能源自西班牙流感病毒及其直接后代引起的感染,可提供针对当前大流行病毒的保护性免疫。

相似文献

1
High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland.在芬兰老年人中,针对 2009 年甲型 H1N1 流感病毒的交叉反应性抗体的高频出现。
Euro Surveill. 2010 Feb 4;15(5):19478.
2
Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.健康志愿者体内针对大流行的A/加利福尼亚/07/2009(H1N1)流感病毒的血清型特异性或交叉反应性神经氨酸酶抑制抗体。
BMC Res Notes. 2015 Apr 10;8:136. doi: 10.1186/s13104-015-1086-z.
3
Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population.2009 年甲型 H1N1 流感大流行在法国大都市人群中的血清学研究。
Clin Microbiol Infect. 2012 Feb;18(2):177-83. doi: 10.1111/j.1469-0691.2011.03545.x. Epub 2011 Jun 2.
4
Age-associated cross-reactive antibody-dependent cellular cytotoxicity toward 2009 pandemic influenza A virus subtype H1N1.与年龄相关的 2009 年甲型 H1N1 流感病毒亚型的交叉反应性抗体依赖的细胞毒性。
J Infect Dis. 2013 Oct 1;208(7):1051-61. doi: 10.1093/infdis/jit294. Epub 2013 Jun 28.
5
Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.对2009年甲型H1N1流感大流行病毒的交叉反应性抗体应答。
N Engl J Med. 2009 Nov 12;361(20):1945-52. doi: 10.1056/NEJMoa0906453. Epub 2009 Sep 10.
6
Sero-immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong Kong.香港人群对甲型 H1N1 流感病毒的血清学免疫和血清学反应。
J Med Virol. 2010 Nov;82(11):1809-15. doi: 10.1002/jmv.21895.
7
[A survey of levels of antibodies against influenza viruses in the population of Wuxi City].[无锡市人群流感病毒抗体水平调查]
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011 Oct;25(5):351-4.
8
Antibodies against swine influenza virus neutralize the pandemic influenza virus A/H1N1.抗猪流感病毒抗体可中和甲型 H1N1 大流行流感病毒。
Mol Med Rep. 2011 Mar-Apr;4(2):209-14. doi: 10.3892/mmr.2011.410. Epub 2011 Jan 3.
9
Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature.1957年H2N2大流行期间克利夫兰家庭研究参与者先前的H1N1流感感染情况及易感性:一项自然实验。
J Infect Dis. 2006 Jan 1;193(1):49-53. doi: 10.1086/498980. Epub 2005 Nov 21.
10
Molecular characterization and phylogenetic analysis of the hemagglutinin 1 protein of human influenza A virus subtype H1N1 circulating in Kenya during 2007-2008.2007-2008 年肯尼亚流行的 H1N1 型人甲型流感病毒血凝素 1 蛋白的分子特征和系统进化分析。
J Infect Dis. 2012 Dec 15;206 Suppl 1:S46-52. doi: 10.1093/infdis/jis586.

引用本文的文献

1
Immune interference in effectiveness of influenza and COVID-19 vaccination.免疫干扰对流感和 COVID-19 疫苗效果的影响。
Front Immunol. 2023 Apr 19;14:1167214. doi: 10.3389/fimmu.2023.1167214. eCollection 2023.
2
The Bone Marrow as Sanctuary for Plasma Cells and Memory T-Cells: Implications for Adaptive Immunity and Vaccinology.骨髓作为浆细胞和记忆 T 细胞的庇护所:对适应性免疫和疫苗学的影响。
Cells. 2021 Jun 15;10(6):1508. doi: 10.3390/cells10061508.
3
Pathogenesis of pandemic H1N1 2009 influenza virus infection and the implication on management.
2009年甲型H1N1流感大流行病毒感染的发病机制及其对治疗的启示。
Front Med China. 2010;4(2):147-156. doi: 10.1007/s11684-010-0030-9. Epub 2010 Apr 28.
4
Role of Multivalency and Antigenic Threshold in Generating Protective Antibody Responses.多价性和抗原阈值在产生保护性抗体反应中的作用。
Front Immunol. 2019 May 1;10:956. doi: 10.3389/fimmu.2019.00956. eCollection 2019.
5
Increased frequency of travel in the presence of cross-immunity may act to decrease the chance of a global pandemic.在存在交叉免疫的情况下增加旅行频率可能会降低全球大流行的机会。
Philos Trans R Soc Lond B Biol Sci. 2019 Jun 24;374(1775):20180274. doi: 10.1098/rstb.2018.0274.
6
Immunogenicity of Influenza Vaccines: Evidence for Differential Effect of Secondary Vaccination on Humoral and Cellular Immunity.流感疫苗的免疫原性:二次接种对体液和细胞免疫的差异影响的证据。
Front Immunol. 2019 Jan 29;9:3103. doi: 10.3389/fimmu.2018.03103. eCollection 2018.
7
Viral Replicative Capacity, Antigen Availability via Hematogenous Spread, and High T:T Ratios Drive Induction of Potent Neutralizing Antibody Responses.病毒复制能力、通过血液传播的抗原可用性和高 T:T 比值驱动强效中和抗体应答的诱导。
J Virol. 2019 Mar 5;93(6). doi: 10.1128/JVI.01795-18. Print 2019 Mar 15.
8
Back to the Future: Lessons Learned From the 1918 Influenza Pandemic.重回未来:从 1918 年流感大流行中吸取的教训。
Front Cell Infect Microbiol. 2018 Oct 8;8:343. doi: 10.3389/fcimb.2018.00343. eCollection 2018.
9
A naturally protective epitope of limited variability as an influenza vaccine target.作为流感疫苗靶点的具有有限变异性的天然保护性表位。
Nat Commun. 2018 Sep 21;9(1):3859. doi: 10.1038/s41467-018-06228-8.
10
H1N1pdm09 Influenza Virus and Its Descendants Lack Extra-epitopic Amino Acid Residues Associated With Reduced Recognition by M158-66-Specific CD8+ T Cells.H1N1pdm09 流感病毒及其后代缺乏与 M158-66 特异性 CD8+ T 细胞识别减少相关的额外表位氨基酸残基。
J Infect Dis. 2018 Jul 13;218(4):581-585. doi: 10.1093/infdis/jiy218.